Insulet (NSDQ:PODD) shares took a hit today after the company reported second-quarter revenues that missed the consensus forecast and cut its outlook for the rest of the year.
Billerica, Mass.-based Insulet reported losses of -$1.7 million, or -3¢ per share, on sales of $124.3 million for the three months ended June 30, amounting to a -78.2% reduction in losses on sales growth of 13.2% compared with Q2 2017. Analysts on Wall Street were looking for losses of -13¢, but expected sales of $132.9 million.
Get the full story on our sister site, Drug Delivery Business News.
The post Insulet slides on Q2 revenue miss appeared first on MassDevice.
from MassDevice https://ift.tt/2OHEHld
Cap comentari:
Publica un comentari a l'entrada